Universitaetsklinikum Bonn AöR

Bonn 53127

1 studies enrolling now · 2 studies all time

What they study most

Indolent Non-Hodgkin Lymphoma, Melanoma, Cutaneous Malignant

Studies at this site

• SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma — Recruiting now
• A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma — Completed